Cargando…

High-Dose Chemotherapy in Children with Newly Diagnosed Medulloblastoma

SIMPLE SUMMARY: Medulloblastoma is the most common malignant central nervous system tumor in the pediatric population. Treatment modalities are stratified by age, extent of resection, metastatic status, histology, and more recently, tumor biology. Maximal surgical resection followed by risk-adapted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lafay-Cousin, Lucie, Dufour, Christelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834150/ https://www.ncbi.nlm.nih.gov/pubmed/35159104 http://dx.doi.org/10.3390/cancers14030837

Ejemplares similares

MBCL-19. CHEMOTHERAPY STRATEGIES FOR YOUNG CHILDREN NEWLY DIAGNOSED WITH DESMOPLASTIC/EXTENSIVE NODULAR MEDULLOBLASTOMA UP TO THE ERA OF MOLECULAR PROFILING – A COMPARATIVE OUTCOMES ANALYSIS OF PROSPECTIVE MULTI-CENTER EUROPEAN AND NORTH AMERICAN TRIALS
por: Finlay, Jonathan L, et al.
Publicado: (2020)

Meta of classical chemotherapy compared with high-dose chemotherapy and autologous stem cell rescue in newly diagnosed medulloblastoma after radiotherapy
por: Zhang, Mengting, et al.
Publicado: (2022)

Reduced-dose craniospinal radiotherapy followed by high-dose chemotherapy and autologous stem cell rescue for children with newly diagnosed high-risk medulloblastoma or supratentorial primitive neuroectodermal tumor
por: Kim, Sun Young, et al.
Publicado: (2010)

Fatal Gastrointestinal Hemorrhage in a Young Boy with Newly Diagnosed Metastatic Medulloblastoma on High Dose Dexamethasone
por: Wong, Victor, et al.
Publicado: (2014)

High-dose chemotherapy with reduced-dose craniospinal radiotherapy in children with newly diagnosed high-risk brain tumor
por: Chung, Nack-Gyun
Publicado: (2010)

Impact of radiation avoidance on survival and neurocognitive outcome in infant medulloblastoma
por: Lafay–Cousin, L., et al.
Publicado: (2009)

A Pilot Study of Low-Dose Craniospinal Irradiation in Patients With Newly Diagnosed Average-Risk Medulloblastoma
por: Minturn, Jane E., et al.
Publicado: (2021)

MEDB-49. Relapsed SHH medulloblastomas in young children. Are there alternatives to full-dose craniospinal irradiation?
por: Erker, Craig, et al.
Publicado: (2022)

Role of neoadjuvant chemotherapy in metastatic medulloblastoma: a comparative study in 92 children
por: Guerrini-Rousseau, Léa, et al.
Publicado: (2020)

MBCL-14. A STUDY OF LOW-DOSE CRANIOSPINAL RADIATION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED AVERAGE-RISK MEDULLOBLASTOMA
por: Mochizuki, Aaron, et al.
Publicado: (2020)

MBCL-29. PHASE I/II STUDY OF SEQUENTIAL HIGH-DOSE CHEMOTHERAPY WITH STEM CELL SUPPORT IN CHILDREN YOUNGER THAN 5 YEARS OF AGE WITH HIGH-RISK MEDULLOBLASTOMA
por: Dufour, Christelle, et al.
Publicado: (2020)

MBCL-02. ROLE OF PREOPERATIVE CHEMOTHERAPY IN METASTATIC MEDULLOBLASTOMA: A COMPARATIVE STUDY IN 92 CHILDREN
por: Guerrini-Rousseau, Léa, et al.
Publicado: (2020)

MBCL-24. CAN YOUNG CHILDREN WITH RELAPSED MEDULLOBLASTOMA BE SALVAGED AFTER INITIAL IRRADIATION-SPARING APPROACHES?
por: Erker, Craig, et al.
Publicado: (2020)

MBCL-32. HIGH-DOSE CHEMOTHERAPY WITH STEM CELL RESCUE FOR RECURRENT PREVIOUSLY IRRADIATED MEDULLOBLASTOMA
por: Salnikova, Ekaterina, et al.
Publicado: (2020)

Proton beam therapy with concurrent chemotherapy is feasible in children with newly diagnosed rhabdomyosarcoma
por: Suzuki, Ryoko, et al.
Publicado: (2021)

MBCL-37. CHEMOTHERAPY STRATEGIES FOR YOUNG CHILDREN NEWLY DIAGNOSED WITH CLASSIC (CLMB) OR ANAPLASTIC/LARGE CELL (A/LCMB) MEDULLOBLASTOMA UP TO THE ERA OF MOLECULAR PROFILING – A COMPARATIVE OUTCOMES ANALYSIS
por: Finlay, Jonathan, et al.
Publicado: (2020)

Metastatic Medulloblastoma in Childhood: Chang's Classification Revisited
por: Dufour, Christelle, et al.
Publicado: (2012)

NFB-12. Effect of trametinib on leg length discrepancy in a child with NF1 related plexiform neurofibroma
por: Pradeep, Celia, et al.
Publicado: (2022)

MBCL-28. LONG-TERM FOLLOW-UP RESULTS OF REDUCED DOSE CRANIOSPINAL RADIOTHERAPY AND TANDEM HIGH-DOSE CHEMOTHERAPY IN PATIENTS WITH HIGH-RISK MEDULLOBLASTOMA
por: Lee, Ji Won, et al.
Publicado: (2020)

Venetoclax for the treatment of newly diagnosed acute myeloid leukemia in patients who are ineligible for intensive chemotherapy
por: Richard-Carpentier, Guillaume, et al.
Publicado: (2019)

A pilot study of EVAP/ABV chemotherapy in 25 newly diagnosed children with Hodgkin's disease.
por: Ekert, H., et al.
Publicado: (1993)

Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia
por: Grainger, John D., et al.
Publicado: (2021)

High-dose thiotepa-related neurotoxicity and the role of tramadol in children
por: Maritaz, Christophe, et al.
Publicado: (2018)

Circular RNA profiling distinguishes medulloblastoma groups and shows aberrant RMST overexpression in WNT medulloblastoma
por: Rickert, Daniel, et al.
Publicado: (2021)

LTBK-05. Outcomes of Infants and Young Children with Newly Diagnosed Localized (M0) SHH Medulloblastoma Treated on The NEXT Consortium “Head Start” 4 Protocol
por: Dhall, Girish, et al.
Publicado: (2022)

Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and Treatment
por: Hill, Rebecca M., et al.
Publicado: (2021)

Promising survival rate but high incidence of treatment‐related mortality after reduced‐dose craniospinal radiotherapy and tandem high‐dose chemotherapy in patients with high‐risk medulloblastoma
por: Lee, Ji Won, et al.
Publicado: (2020)

Treatment of Early Childhood Medulloblastoma by Postoperative Chemotherapy Alone—A Critical Review
por: Komotar, Ricardo J., et al.
Publicado: (2009)

High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma—a randomized phase III trial (MATRix)
por: Schorb, Elisabeth, et al.
Publicado: (2016)

Medulloblastoma has a global impact on health related quality of life: Findings from an international cohort
por: de Medeiros, Cynthia B., et al.
Publicado: (2019)

Clinical, pathological, and molecular data on desmoplastic/nodular medulloblastoma: case studies and a review of the literature
por: Siegfried, Aurore, et al.
Publicado: (2016)

XRT-07. LATE-ONSET LYMPHOPENIA DURING CRANIOSPINAL RADIATION IS ASSOCIATED WITH AN INCREASED RISK OF TUMOR RECURRENCE IN NEWLY-DIAGNOSED PEDIATRIC MEDULLOBLASTOMA
por: Lindsay, Holly, et al.
Publicado: (2023)

Advances in therapeutic options for newly diagnosed, high-risk AML patients
por: Doucette, Kimberley, et al.
Publicado: (2021)

Cardiovascular events and treatment of children with high risk medulloblastoma
por: Cuomo, Alessandra, et al.
Publicado: (2021)

Phase II trial of dose-dense chemotherapy followed by dose-intense erlotinib for patients with newly diagnosed metastatic non-small cell lung cancer
por: PETTY, W. JEFFREY, et al.
Publicado: (2013)

Association of high‐dose radiotherapy with improved survival in patients with newly diagnosed low‐grade gliomas
por: Liu, Yanwei, et al.
Publicado: (2021)

c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients
por: von Bueren, André O, et al.
Publicado: (2011)

High Frequency of Diabetic Ketoacidosis in Children with Newly Diagnosed Type 1 Diabetes
por: Szypowska, Agnieszka, et al.
Publicado: (2016)

Medulloblastoma stem cells: Promising targets in medulloblastoma therapy
por: Huang, Guo‐Hao, et al.
Publicado: (2016)

MEDB-04. Young children with metastatic medulloblastoma: frequent requirement for radiotherapy in children with non-WNT/non-SHH medulloblastoma despite highly intensified chemotherapy – Results of the MET-HIT2000-BIS4 trial
por: Mynarek, Martin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5dfu8h4mhng94tmora3lq5ob7g